Fortress Biotech (FBIO) DEF 14A: Executive Compensation Details
Ticker: FBIOP · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1429260
Sentiment: neutral
Topics: executive-compensation, equity-awards, sec-filing
Related Tickers: FBIO
TL;DR
FBIO DEF 14A out: Exec comp details for 2024, focus on equity awards. Check vesting & fair value.
AI Summary
Fortress Biotech, Inc. (FBIO) filed a DEF 14A on April 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to both principal executive officers (PEO) and non-principal executive officers (Non-PEO), with specific data points on year-end fair values and vesting dates for these awards.
Why It Matters
This filing provides transparency into how Fortress Biotech compensates its top executives, which can influence investor perception and the company's ability to attract and retain talent.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures of executive compensation, but the specifics can reveal potential issues or positive trends in management incentives and company performance.
Key Numbers
- 20250428 — Filing Date (Date the DEF 14A was filed with the SEC.)
- 2024-12-31 — Fiscal Year End (The end date of the fiscal year for which executive compensation is detailed.)
Key Players & Entities
- Fortress Biotech, Inc. (company) — Filer of the DEF 14A
- 0001429260 (company) — Central Index Key for Fortress Biotech, Inc.
- 20250428 (date) — Filing date of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for which compensation data is reported
FAQ
What is the total reported fair value of equity awards granted to PEOs in the fiscal year ending 2024?
The filing indicates data points for 'YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember' for the period 2024-01-01 to 2024-12-31, but the specific dollar amount is not provided in the excerpt.
What is the total reported fair value of equity awards granted to Non-PEOs in the fiscal year ending 2024?
The filing indicates data points for 'YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember' for the period 2024-01-01 to 2024-12-31, but the specific dollar amount is not provided in the excerpt.
When were the equity awards granted to Non-PEOs vested in the fiscal year ending 2024?
The filing references 'VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember' for the period 2024-01-01 to 2024-12-31, suggesting vesting dates are detailed, but specific dates are not in the excerpt.
What was the change in fair value of outstanding and unvested equity awards granted in prior years to PEOs during the fiscal year ending 2024?
The filing mentions 'ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember' for the period 2024-01-01 to 2024-12-31, indicating this data is present, but the specific change in value is not in the excerpt.
What is the filing date of this DEF 14A?
The DEF 14A filing was made on April 28, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Fortress Biotech, Inc. (FBIOP).